1) 1,25-(OH)2Vitamin D3
1,25-(OH)2维生素D3
1.
Results:After EC9706 cells were exposed to 1,25-(OH)2Vitamin D3 for 1~5 d, the mean absorbance values at 490 nm at different time points were lower than those in control group(P<0.
目的:观察1,25-(OH)2维生素D3对食管癌EC9706细胞细胞增殖、细胞周期、食管癌细胞裸鼠移植瘤生长及对NDRG1蛋白表达的影响。
2) 1,25-dihydroxy vitamin D3
1,25(OH)2维生素D3
3) 1,25-dihydroxyvitamin D3
1,25二羟维生素D3
1.
Objective To study the effect of different concentration of 1,25-dihydroxyvitamin D3[1,25(OH)2D3] on cell proliferation,differentiation and the expression of vitamin D receptor (VDR) in mouse MC3T3E1 osteoblast.
目的研究不同浓度1,25二羟维生素D3[1,25(OH)2D3]对小鼠成骨细胞增殖分化及维生素D受体(VDR)表达的影响,探讨VDR在成骨细胞增殖分化中的作用。
2.
Reserch Progress About Effect of 1,25-dihydroxyvitamin D3 on Mesangial Cell;
随着对维生素D的深入研究,发现其活性形式1,25二羟维生素D3(1,25(OH)2D3)除了具有经典的钙、磷代谢调节作用外,还具有广泛的生物学效应。
4) 1,25-Dihydroxyvitamin D3
1,25-二羟维生素D3
1.
Immunomodulatory effects of 1,25-dihydroxyvitamin D3;
1,25-二羟维生素D3的免疫调节作用
2.
The active form of vitamin D,1,25-Dihydroxyvitamin D3 \,is a secosteroid hormone that binds to the vitamin D receptor(VDR),a member of the superfamily of nuclear receptors for steroid hormones,thyroid hormone,and retinoic acid.
1,25-二羟维生素D3是维生素D的活性形式,是一种第二类固醇类激素,和维生素D受体(VDR)结合发挥作用。
3.
Objective To study the effects of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on the expression of osteoprotegerin (OPG) and receptor activator of NF-KB ligand (RANKL) mRNA in mouse osteoblasts.
目的 观察1,25-二羟维生素D3[1,25(OH)2D3]对体外培养的小鼠成骨细胞osteoprotegerin(OPG)和receptor activator of NF-κB ligand(RANKL)基因表达的作用。
5) 1,25-dihydroxyvitamin D_3
1,25二羟维生素D3
1.
Effect of 1,25-dihydroxyvitamin D_3 and Tamoxifen on cell cycle distribution and apoptosis of MDA-MB-231 cells transfected with ERα expression vector containing vitamin D response element;
目的构建受1,25二羟维生素D3调控的雌激素受体α真核表达载体(VDRE-Tk-ERα),并观察其对雌激素受体阴性乳腺癌细胞的细胞周期相分布和凋亡的影响。
6) 1,25-hydroxyvitam D_3
1,25双羟维生素D3
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条